AI English summary of an SEC filing — figures as filed
Boston Scientific BSXThe company said the Board appointed Jonathan Monson as Senior Vice President, Investor Relations on January 26, 2024, effective March 1, 2024.
Key points
AI summaryThe company said the Board appointed Jonathan Monson as Senior Vice President, Investor Relations on January 26, 2024, effective March 1, 2024.
Boston Scientific said Monson has served as Senior Vice President, Global Controller and Chief Accounting Officer since July 2019, and will no longer serve as Chief Accounting Officer of the company as of March 1, 2024.
The company said the Board appointed Emily Woodworth (Collins), age 46, as Senior Vice President, Global Controller and Chief Accounting Officer on January 26, 2024, effective March 1, 2024.
Woodworth has served as Vice President of Finance and Controller for the Urology business since July 2019, the company said, and previously served as Director of Global Technical Accounting and External Reporting from April 2016 through July 2019. The company said Woodworth is expected to receive a base salary and participate in the annual bonus plan and incentive stock awards program.
Summary
AI-writtenAnalysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
Jonathan Monson Appointed Senior Vice President, Investor Relations
The company said the Board appointed Jonathan Monson as Senior Vice President, Investor Relations on January 26, 2024, effective March 1, 2024.
Source · Based on the filing body and exhibits
Monson To Step Down as Chief Accounting Officer Effective March 1, 2024
Boston Scientific said Monson has served as Senior Vice President, Global Controller and Chief Accounting Officer since July 2019, and will no longer serve as Chief Accounting Officer of the company as of March 1, 2024.
Source · Based on the filing body and exhibits
Emily Woodworth Appointed Senior Vice President, Global Controller and Chief Accounting Officer
The company said the Board appointed Emily Woodworth (Collins), age 46, as Senior Vice President, Global Controller and Chief Accounting Officer on January 26, 2024, effective March 1, 2024.
Source · Based on the filing body and exhibits
Woodworth Career and Compensation Structure
Woodworth has served as Vice President of Finance and Controller for the Urology business since July 2019, the company said, and previously served as Director of Global Technical Accounting and External Reporting from April 2016 through July 2019. The company said Woodworth is expected to receive a base salary and participate in the annual bonus plan and incentive stock awards program.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…